0001181431-12-042706.txt : 20120730 0001181431-12-042706.hdr.sgml : 20120730 20120730165805 ACCESSION NUMBER: 0001181431-12-042706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120726 FILED AS OF DATE: 20120730 DATE AS OF CHANGE: 20120730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDO DALE G CENTRAL INDEX KEY: 0001202278 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 12994251 MAIL ADDRESS: STREET 1: C/O CELL GENESYS INC STREET 2: 500 FORBES BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 4 1 rrd351928.xml FORM 4 X0306 4 2012-07-26 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001202278 ANDO DALE G C/O SANGAMO BIOSCIENCES INC. POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 0 1 0 0 VP, Therapeutic Dev. & CMO Common Stock 2012-07-26 4 S 0 1000 5.12 D 77534 D Common Stock 2012-07-26 4 S 0 1500 5.09 D 76034 D Common Stock 2012-07-26 4 S 0 1500 5.04 D 74534 D Common Stock 2012-07-26 4 S 0 500 5.02 D 74034 D Common Stock 2012-07-26 4 S 0 500 4.99 D 73534 D Common Stock 2012-07-27 4 M 0 15000 3.61 A 88534 D Common Stock 2012-07-27 4 S 0 15000 5.60 D 73534 D Employee Stock Option (Right to Buy) 3.61 2012-07-27 4 M 0 15000 0 D 2014-08-01 Common Stock 15000 95800 D The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2012. Includes 2,000 shares acquired by the Reporting Person on April 30, 2012 under the Issuer's Employee Stock Purchase Plan. All shares underlying this option are vested and immediately exercisable. /s/ Dale G. Ando 2012-07-26